CAJ | 학술논문

目的：探讨血塞通注射液治疗急性出血性脑血管病的临床疗效。方法从该院2010年10月-2013年10月收治的急性出血性脑血管病患者中随机选择100例进行研究，随机分为两组，并别给予血塞通注射液治疗和常规治疗。结果观察组不良反应发生率为2.0%，对照组为14.0%。经比较，差异无统计学意义（P＞0.05）；观察组的最终总有效率为96.0%，对照组为78.0%，经比较，差异有统计学意义（P＜0.05）。结论血塞通注射液治疗急性出血性脑血管病，不良反应较少，疗效确切，值得推广。
목적：탐토혈새통주사액치료급성출혈성뇌혈관병적림상료효。방법종해원2010년10월-2013년10월수치적급성출혈성뇌혈관병환자중수궤선택100례진행연구，수궤분위량조，병별급여혈새통주사액치료화상규치료。결과관찰조불량반응발생솔위2.0%，대조조위14.0%。경비교，차이무통계학의의（P＞0.05）；관찰조적최종총유효솔위96.0%，대조조위78.0%，경비교，차이유통계학의의（P＜0.05）。결론혈새통주사액치료급성출혈성뇌혈관병，불량반응교소，료효학절，치득추엄。
Objective To investigate the clinical efficacy of Xuesaitong Injection in the treatment of acute hemorrhagic cerebrovas-cular disease. Methods 110 cases of patients with acute hemorrhagic cerebrovascular disease admitted in our hospital from Octo-ber, 2010 to October, 2013 were randomly selected for the study and divided into two groups treated with Xuesaitong Injection therapy and routine therapy, respectively. Results The incidence of adverse reactions of the observation group was 2.0%, and that of the control group was 14.0%, the difference was not statistically significant by comparison (P>0.05). The final total effective rate of the observation group was 96.0%, and that of the control group was 78.0%, the difference was statistically significant by compar-ison(P<0.05). Conclusion For acute hemorrhagic cerebrovascular disease, the curative effect of Xuesaitong Injection is definite with less adverse reactions, which is worthy of promotion.